Exploring the neural correlates of impulsivity and impulsive compulsive behaviors in Parkinson’s disease
Objective: To explore the subcortical neural correlates of impulse control and related behavioral disorders (ICBD) and trait impulsivity in a chronic and naturalistic setting in…Analysing the bradykinesia features combination in people with Parkinson’s disease and elderly healthy individuals
Objective: To evaluate, through kinematic analysis, the major phenomenological features of bradykinesia, with a specific focus on their combination, in a relatively large sample of…Muscle Augmentation Paradox: Contrasting Therapeutic Approaches in Myasthenia Gravis and Parkinson’s Disease
Objective: This exploration aims to dissect the therapeutic paradox presented by muscle augmentation strategies in Myasthenia Gravis (MG) and Parkinson's Disease (PD), offering a comparative…Alterations in Monoamine Metabolites in Parkinson’s Disease: A Meta-Analysis
Objective: To analyze the levels of various monoamine metabolites in patients with Parkinson’s Disease as compared to healthy controls. Background: Monoamine metabolites are the breakdown…Education Levels on Diagnostic Delay Phase and Initial Symptom Perception Among Hispanic Patients with Parkinson’s Disease: A Cross-Sectional Study
Objective: Determine the relationship between education levels and the diagnostic delay phase, along with the age of symptom perception, in Hispanic patients with Parkinson's disease…Parkinson’s disease and Myasthenia Gravis: a case report and literature review
Objective: To present a case of comorbid Parkinson’s disease(PD) and Myasthenia Gravis(MG) and review the literature about the underlying pathogenesis mechanisms and potential treatments. Background:…Cytokine Profiles as Biomarkers for Neurodegenerative Diseases: An inflammatory study on Parkinson’s Disease and Tauopathies
Objective: To investigate the diagnostic and prognostic value of cytokine profiles in cerebrospinal fluid (CSF) and serum of patients with Parkinson's Disease (PD), Progressive Supranuclear…New α-Synuclein Strain Biomarker in Parkinson’s Disease and Related Dementia
Objective: Biomarker development for Parkinson’s disease and related dementia. Background: α-Synuclein (α-syn) strains can serve as discriminators of Parkinson's disease (PD) from other α-synucleinopathies. However,…Focused Ultrasound Therapy Treatment for Parkinson’s Disease
Objective: Parkinson’s Disease is a neurodegenerative disease that mainly affects the substantia nigra and nigrostriatal pathway and leads to rigidity, loss of muscle tone, tremors,…Exploring Retrospectively the Predisposing Factors of Sleep Disorders in Parkinson’s Disease.
Objective: Identify the predisposing or exacerbating factors of sleep disorders in Parkinson's disease, and examine their association with levodopa treatment. Background: Parkinson's disease (PD) is…
- « Previous Page
- 1
- …
- 178
- 179
- 180
- 181
- 182
- …
- 436
- Next Page »